Patents by Inventor Kazuyuki Yazawa

Kazuyuki Yazawa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Anaerobic bacterium as a drug for cancer gene therapy
    Patent number: 7740835
    Abstract: The present invention provides a bacterium belonging to the genus Bifidobacterium, by which DNA coding for a protein having an antitumor activity or DNA coding for a protein having the activity of converting a precursor of an antitumor substance into the antitumor substance is delivered to tumor tissues specifically under anaerobic conditions thereby expressing the protein encoded by the DNA, as well as a pharmaceutical composition comprising said anaerobic bacterium.
    Type: Grant
    Filed: February 23, 2004
    Date of Patent: June 22, 2010
    Assignee: Anaeropharma Science Inc.
    Inventors: Minoru Fujimori, Shun'ichiro Taniguchi, Jun Amano, Kazuyuki Yazawa, Yasunobu Kano, Toshiyuki Nakamura, Takayuki Sasaki
  • Anaerobic bacterium as a drug for cancer gene therapy
    Publication number: 20050025745
    Abstract: The present invention provides a bacterium belonging to the genus Bifidobacterium, by which DNA coding for a protein having an antitumor activity or DNA coding for a protein having the activity of converting a precursor of an antitumor substance into the antitumor substance is delivered to tumor tissues specifically under anaerobic conditions thereby expressing the protein encoded by the DNA, as well as a pharmaceutical composition comprising said anaerobic bacterium.
    Type: Application
    Filed: February 23, 2004
    Publication date: February 3, 2005
    Inventors: Minoru Fujimori, Shun'ichiro Taniguchi, Jun Amano, Kazuyuki Yazawa, Yasunobu Kano, Toshiyuki Nakamura, Takayuki Sasaki
  • Anaerobic bacterium as a drug for cancer gene therapy
    Publication number: 20020054865
    Abstract: The present invention provides a bacterium belonging to the genus Bifidobacterium, by which DNA coding for a protein having an antitumor activity or DNA coding for a protein having the activity of converting a precursor of an antitumor substance into the antitumor substance is delivered to tumor tissues specifically under anaerobic conditions thereby expressing the protein encoded by the DNA, as well as a pharmaceutical composition comprising said anaerobic bacterium.
    Type: Application
    Filed: March 26, 2001
    Publication date: May 9, 2002
    Inventors: Minoru Fujimori, Shun?apos;ichiro Taniguchi, Jun Amano, Kazuyuki Yazawa, Yasunobu Kano, Toshiyuki Nakamura, Takayuki Sasaki